Epidemiological co-occurrence of dengue and Covid-19 in Peru

dc.contributor.authorOseda Gago, Dulio
dc.contributor.authorDurán Carhuamaca, Amanda
dc.contributor.authorHuallpa Quispe, Patricia Matilde
dc.contributor.authorCastillo Rodriguez, María Nelly
dc.description.abstractEn Perú, la enfermedad del dengue sigue en aumento durante la pandemia por Covid-19, siendo un tema de preocupación para la salud pública. Por esto, se realizó un estudio descriptivo-retrospectivo con datos secundarios de las fichas de notificación del MINSA tanto para dengue como Covid-19, aplicando indicadores epidemioógicos como tasa de incidencia acumulada para dengue, tasa de ataque para covid-19 y elaboracón de canales endémicos. Como resultado, el comportamiento epidemiológico del dengue entre 2018-2021 fue endémico con picos en la semana epidemiológica SE 46-2019, SE 47-2019 y SE 50-2021, respecto al SARS-CoV-2, para 2022, tuvo un valor Rt = 2,08 (1,07-3,56) (>1), es decir, la tasa de contagio es superior a la tasa de recuperación, ahora bien, para explicar si el advenimiento del Covid-19 tuvo una influencia en el comportamiento de la incidencia dengue, la construcción de los canales enémicos para 2019, 2020 y 2021, permitió observar que esta arbovirosis tiene un comportamiento endémico entre las SE 1 a 40 de 2019 (áreas de éxito y seguridad); mientras que, apartir de la SE 41-2019, se observa un comportamiento epidémico fluctuante, que sale del área de epidemia únicamente en los periódos de la SE 17 A 26 de 2020 y 15 a 21 de 2021. Es de gran relevancia señalar que este brote epidémico se inició 20 semanas antes de la declaración del primer contagio por SARS-CoV-2 en Perú. Finalmente, se concluye que el comportamiento del dengue en esta nación es independiente a la coocurrencia con la pandemia Covid-19.. Dengue is the most common arbovirus worldwide, with more than 128 countries showing evidence of endemic dengue transmission and almost 4 billion people living in areas at risk of infection. The World Health Organization has an estimate of 96 million symptomatic infections per year. In this sense, for the year 2003, the 44th Directing Council of PAHO/WHO recognized Resolution CD44.R9, which promoted the approaches of national programs, introducing models of Integrated Management Strategy (EGI)-dengue creating related technical groups in different regions. In this sense, a documentary study of primary and secondary sources of free access of official bodies of Peru was developed to evaluate the digital availability of the EGI-dengue objectives, according to the questionnaire published by PAHO. The results showed a 65.22% compliance with the proposed objectives, which is somewhat low considering the importance of this endemic disease. The objectives with the greatest dissatisfaction were operational research (70%), patient care (50%), and integrated vector management (50%); while the most satisfactory objectives were: communication and promotion (80%), environment, epidemiology and general process with 100% respectively. These percentage values allow adjustments to be made in order to improve these less worked aspects, look at their weaknesses and propose new actions, maximizing the benefits of the evaluation process.
dc.description.abstractIn Peru, dengue disease continues to increase during the Covid-19 pandemic, being a matter of concern for public health. For this reason, a descriptiveretrospective study was Carried out with secondary data from the MINSA notification sheets for both dengue and Covid-19, applying epidemiological indicators such as accumulated incidence rate for dengue, attack rate for covid-19 and elaboration of channels. endemic. As a result, the epidemiological behavior of dengue between 2018-2021 was endemic with peaks in the epidemiological week SE 46-2019, SE 47-2019 and SE 50-2021, with respect to SARS-CoV-2, for 2022, it had an Rt value = 2.08 (1.07-3.56) (>1), that is, the contagion rate is higher than the recovery rate, however, to explain whether the advent of Covid-19 had an influence on the behavior of the dengue incidence, the construction of the enemic channels for 2019, 2020 and 2021, allowed us to observe that this arbovirosis has an endemic behavior between EW 1 to 40 of 2019 (areas of success and safety); while, apart from EW 41-2019, a fluctuating epidemic behavior is observed, which leaves the epidemic area only in the periods of EW 17 to 26 of 2020 and 15 to 21 of 2021. It is highly relevant to note that this The epidemic outbreak began 20 weeks before the declaration of the first SARS-CoV-2 infection in Peru. Finally, it is concluded that the behavior of dengue in this nation is independent of the co-occurrence with the Covid-19 pandemic.
dc.identifier.citationEpidemiological co-occurrence of dengue and Covid-19 in Peru, Articulo - Escuela Profesional de Ingenieria de Sistemas
dc.publisherUniversidad Nacional de Cañete
dc.subjectCanal endémico
dc.titleEpidemiological co-occurrence of dengue and Covid-19 in Peru
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
1.63 MB
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
1.71 KB
Item-specific license agreed to upon submission